Acute Liver Failure Management
Introduction to N-acetylcysteine (NAC) Therapy
- NAC is the established antidote for acetaminophen poisoning, and its use is strongly recommended for all patients with acute liver failure where acetaminophen overdose is known, suspected, or possible, according to the American Association for the Study of Liver Diseases 1
- NAC works through multiple mechanisms that are beneficial across different etiologies of liver failure, including replenishing hepatic glutathione stores, providing antioxidant effects, exerting immunologic effects, improving microcirculatory blood flow, and enhancing oxygen delivery and consumption, although the exact mechanisms are not fully understood 1, 2
Administration and Dosage
- The recommended intravenous administration of NAC consists of a loading dose of 150 mg/kg in 5% dextrose over 15 minutes, followed by a maintenance dose of 50 mg/kg over 4 hours, and then 100 mg/kg over 16 hours, with a total dose of 300 mg/kg over 21 hours, as suggested by the American Association for the Study of Liver Diseases 1
- For oral administration, the loading dose is 140 mg/kg by mouth or nasogastric tube (diluted to 5% solution), followed by a maintenance dose of 70 mg/kg by mouth every 4 hours for 17 doses, according to the American Association for the Study of Liver Diseases 1
- Intravenous administration is preferred in acute settings, with various dosing regimens used in studies, typically administered for 24-72 hours depending on clinical response 2
Efficacy and Outcomes
- NAC significantly reduces the risk of death when given within 24 hours of ingestion, and improves chances of recovery without the need for liver transplantation, as reported by the American Association for the Study of Liver Diseases 1
- The use of NAC is associated with improved transplant-free survival, with a significant reduction in the need for liver transplantation, according to the American Association for the Study of Liver Diseases 1
- A meta-analysis of adult patients with non-acetaminophen acute liver failure showed improved overall survival (76% vs 59%, OR = 2.30, 95% CI 1.54-3.45, P<0.0001) and significantly better liver transplant-free survival (64% vs 26%, OR = 4.81, 95% CI 3.22-7.18, P<0.0001) 2
- The evidence for NAC in non-acetaminophen liver failure is not as strong as for acetaminophen toxicity, with a GRADE 2 vs GRADE 1 recommendation, although the potential benefits outweigh the risks, making it a reasonable treatment option for all causes of acute liver failure 1, 2
Special Considerations
- NAC should be given even when the time since acetaminophen ingestion is unknown or delayed, and is most effective in the early stages of encephalopathy (grades I-II), as recommended by the American Association for the Study of Liver Diseases 1
- In cases of massive acetaminophen overdose, standard dosing may be insufficient, and individualized dosing may be needed, according to the American Association for the Study of Liver Diseases 1
- Early administration of NAC is critical, and it is most beneficial when started early in the course of liver injury, particularly in patients with early-stage encephalopathy (grades I-II coma) 2
- NAC may be used in cases of acute liver failure when acetaminophen ingestion is possible or when knowledge of circumstances surrounding admission is inadequate, according to the Hepatology guidelines, and has shown potential benefit in various forms of liver failure, including viral hepatitis, alcoholic liver injury, ischemic liver injury, drug-induced liver injury, and mushroom poisoning 1, 2, 3
Monitoring and Side Effects
- Patients on NAC therapy should be monitored for serial liver function tests, coagulation parameters, signs of encephalopathy, and hemodynamic stability 1, 2, 3
- Common side effects of NAC include nausea, vomiting, diarrhea or constipation, while less common side effects include skin rash and transient bronchospasm, and rare but serious side effects include anaphylactic reactions, with an incidence of anaphylactic reactions being more common with IV administration 1, 2
Consultation and Referral
- Patients with acute liver failure should always be consulted with a liver transplantation center early, regardless of the use of NAC, as some patients may still require transplantation despite optimal medical therapy, as suggested by the American Association for the Study of Liver Diseases 1
- The American Association for the Study of Liver Diseases recommends administering NAC to patients with hepatic failure thought to be due to acetaminophen, with a Level B recommendation, and the American College of Emergency Physicians suggests administering NAC to patients who have hepatotoxicity thought to be due to acetaminophen, including repeated supratherapeutic ingestions, with a Level C recommendation 4, 1
- Always consult with a liver transplantation center for patients with acute liver failure, avoid hepatotoxic medications, avoid routine correction of coagulation unless active bleeding, and avoid nephrotoxic drugs including NSAIDs 2
- Consider second-line etiological investigations if first-line examinations are negative 2
| Outcome | NAC Group | Control Group | Odds Ratio | 95% CI | P-value |
|---|---|---|---|---|---|
| Overall Survival | 76% | 59% | 2.30 | 1.54-3.45 | <0.0001 |
| Liver Transplant-Free Survival | 64% | 26% | 4.81 | 3.22-7.18 | <0.0001 |